<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR51">
 <label>51.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Hajizadeh</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Moore</surname>
    <given-names>EE</given-names>
   </name>
   <name>
    <surname>McIntyre</surname>
    <given-names>RC</given-names>
   </name>
   <name>
    <surname>Moore</surname>
    <given-names>PK</given-names>
   </name>
   <name>
    <surname>Veress</surname>
    <given-names>LA</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Tissue plasminogen activator (tPA) treatment for COVID-19-associated acute respiratory distress syndrome (ARDS): a case series</article-title>
  <source>J Thromb Haemostasis.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1111/jth.14828</pub-id>
 </element-citation>
</ref>
